ArticleInternational journal of cancer2021

Risk of cardiovascular disease following gonadotropin-releasing hormone agonists vs antagonists in prostate cancer: Real-world evidence from five databases.

Gincy George et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.